Vaxxas Raises Us$23 Million (A$34 Million) To Clinically Advance Needle-Free Vaccines, Including A Next-Generation Covid-19 Vaccine Candidate
Amount Raised
$23 Million
Round Type
Funding Round
Investors
Description
Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced it has completed a financing round which raised US$23 million (A$34 million) in new funds. This investment round was led by existing investors OneVentures and UniQuest Pty Ltd. New investors include members of the Vaxxas Board of Directors, management team, and a number of individual investors.
Quick answer
Vaxxas raised $23 Million in a Funding Round round, dated December 5, 2022. Investors: One Ventures.
- How much did Vaxxas raise?
- Vaxxas raised $23 Million in a Funding Round round on December 5, 2022.
- Who invested in Vaxxas?
- One Ventures is named as investors in this round.
- What does Vaxxas do?
- Vaxxas is commercializing novel technology that dramatically enhances the performance of existing and next-generation vaccines.
- Where is Vaxxas based and how big is it?
- Fundz records about 127 employees.
- Who are the decision-makers at Vaxxas?
- Fundz holds 1 contact at Vaxxas, including the Chief Business Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Vaxxas that raised within 45 days of this round, from Fundz verified event records.
- Repare Therapeutics raised $1.5M (Seed) on January 19, 2023.
- Eppin Pharma raised an undisclosed amount (Funding Round) on January 19, 2023.
- Arkeon raised an undisclosed amount (Funding Round) on January 19, 2023.
- Genialis raised $11M on January 19, 2023.
- BioProtonics raised $109K (Seed) on January 18, 2023.
- Iaso Bio raised $75M (Series C) on January 18, 2023.
Who to call at Vaxxas, and when
A new round usually means Vaxxas is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Vaxxas raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Vaxxas, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Vaxxas. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Vaxxas raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Vaxxas raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.